Skip to the page

Data / Medical devices / France / Hyphen Biomed Sasu

Hyphen Biomed Sasu: FDA-registered device maker in NEUVILLE SUR OISE Val-d'Oise, France, 7 510(k) clearances

Hyphen Biomed Sasu is registered with the FDA (registration 3004434070) in NEUVILLE SUR OISE Val-d'Oise, France. It lists 10 device types. The FDA files 7 510(k) clearances under its listings, the newest dated May 8, 2009. 2 recall events name it as the recalling firm. Registered through 2026. FDA data exported November 3, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3004434070
Address
155 Rue D Eragny, NEUVILLE SUR OISE Val-d'Oise, France, 95000
Owner or operator
HYPHEN BIOMED (9067801)
Roles
Manufacturer
First device listed
June 18, 2007
Registered through
2026
Brand names listed
AR001B Calcium Chloride 025M (M/40) 3X15ml, AR001K Calcium chloride 0,025M (M/40) Set of 12x25 ml, AR001L Calcium Chloride 025M (M/40) 12x15ml, AR021B Imidazole buffer 1x15ml, AR021K Imidazole buffer 3x25 ml, AR021L Imidazole buffer 12x25 ml, AR021M Imidazole buffer 3x15ml, AR021N Imidazole buffer 12x15ml and more

Devices it lists

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
May 8, 2009K083729HEMOCLOT QUANTI- V-L, FACTOR V-L CALIBRATOR, BIOPHEN V-L CAL (UNDILUTED), BIOPHEN ACT. PC-R CONTROL PLASMA AND BIOPHENGGWSubstantially EquivalentAniara Diagnostica, LLCaccessdata.fda.gov
September 7, 2007K071255ZYMUTEST HIA IGGAM, ZYMUTEST IGG, MODEL RK040D, RK040ALCOSubstantially EquivalentHyphen Biomedaccessdata.fda.gov
May 24, 2006K050367BIOPHEN HEPARIN 3, BIOPHEN HEPARIN 6KFFSubstantially EquivalentHyphen Biomedaccessdata.fda.gov
December 27, 2005K050365BIOPHEN PROTEIN C5, C2.5, MODELS 221205, 221202GGPSubstantially EquivalentHyphen Biomedaccessdata.fda.gov
December 23, 2005K051472BIOPHEN LMWH CONTROL, LMWH CONTROL LOW, UFH CONTROL, HEPARIN CALIBRATOR & UFH CALIBRATORGGNSubstantially EquivalentHyphen Biomedaccessdata.fda.gov
November 7, 2005K043007BIOPHEN ANTITHROMBIN 2.5, REFERENCE # 221102; BIOPHEN ANTITHROMBIN 5, REFERENCE # 221105JBQSubstantially EquivalentHyphen Biomedaccessdata.fda.gov
March 17, 2005K043451BIOPHEN NORMAL AND ABNORMAL CONTROL PLASMA; BIOPHEN PLASMA CALIBRATORGGNSubstantially EquivalentHyphen Biomedaccessdata.fda.gov

Recalls

Recall events where this establishment is the recalling firm, matched on its FEI.

InitiatedEventClassStatusProductReasonSource
February 5, 201879797Class IITerminatedZYMUTEST HIA MonoStrip IgG; REF Number: RK041A; UDI: 03663537046803 a qualitative assay intended for the detection of heparin-dependent antibodies of the IgG isotype, in human plasma, by clinical laboratories. It is inteIncorrect package insert indicating use of the kits with plasma, serum, and other biological fluids. The kits should only be used with plasma.accessdata.fda.gov
November 9, 201179269Class IITerminatedZYMUTEST HIA IgGAM. Model Number: RK040D. Qualitative screening assay for the detection of heparin-dependent antibodies (IgG, IgM and IgA isotypes by ELISA. 96 Tests.A voluntary recall is initiated for ZYMUTEST HIA lgGAM - Ref RK040D - Lot F1700415 and ZYMUTEST HIA MonoStrip lgGAM - Ref RK041D - Lot F1700416 because they may produce false positive results.accessdata.fda.gov

Compare with other makers

Updated May 8, 2009. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.